Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial.
Saved in:
| Title: | Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial. |
|---|---|
| Authors: | Frias JP; National Research Institute, Los Angeles, California., Gonzalez-Galvez G; Jalisco Institute of Diabetes and Obesity Research, Guadalajara, Mexico., Johnsson E; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Maaske J; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Testa MA; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Simonson DC; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Dronamraju N; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Garcia-Sanchez R; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Peters AL; Keck School of Medicine of the University of Southern California, Los Angeles, California. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2020 Jul; Vol. 22 (7), pp. 1083-1093. Date of Electronic Publication: 2020 Mar 09. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.13997 |
